Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford, in association with the John Black Charitable Foundation, is pleased to welcome Dr Ira Milosevic as a John Black Senior Research Fellow in Parkinson’s Disease Research.

Ira Milosevic

The John Black Senior Research Fellowship aims to build on the strengths of the University's Central Nervous System (CNS) research programmes and world leading research into the discovery and translation of novel therapeutic approaches for neurodegenerative diseases, with a particular focus on Parkinson's disease. As a principal investigator, Dr Milosevic will provide strategic and academic leadership, pioneering studies and development of worldwide scientific collaborations.

"My colleagues and I are delighted to be welcoming Dr Milosevic to the University of Oxford and Nuffield Department of Medicine", says Dr Davis, CSO of the ARUK Oxford Drug Discovery Institute (ODDI), "Disturbances in the normal function of subcellular organelles has been highlighted as a possible cause of several neurodegenerative diseases and Ira's expertise in the field will provide a major boost to expansion of our understanding of the functional genetics of Parkinson's disease, in particular".

Dr Milosevic, who joins the University from the European Neuroscience Institute – Göttingen, said: "I am honoured to accept the John Black Senior Research Fellowship and excited to be joining the University of Oxford. I am extremely grateful to the John Black Charitable Foundation for providing financial support and for their efforts to promote translational research in Parkinson's disease. I look forward to helping advance their important mission and to collaborating with the exceptional faculty and students at the Nuffield Department of Medicine and Wellcome Centre for Human Genetics. "

About the John Black Charitable Foundation

John Black Charitable Foundation (JBCF) was created out of the Will of the Late John Black. The aim of JBCF is to promote quality research in the areas of Parkinson's disease and Prostate Cancer. Since its inception, JBCF has committed substantial funding for a large number of research projects at many of the UK's leading institutions.

Similar stories

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.

Major funding for Oxford will help find new cancer treatments

Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.

Daniel Freeman to join Department of Experimental Psychology as Professor of Psychology

The Department of Experimental Psychology are delighted to announce that Daniel Freeman has been appointed as their new Professor of Psychology, joining from the Department of Psychiatry.

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant

The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.